Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 8 for Fresenius Medical Care Renal Therapies Group, LLC.
Fresenius Medical Care Renal Therapies Group, LLC: 0 warning letters, 8 recalls, 0 approval records, 0 Form 483s.
Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.
Side by side
Fresenius Medical Care Renal Therapies Group, LLC — Warning letters0
Philips North America — Warning letters0
Fresenius Medical Care Renal Therapies Group, LLC — Recalls8
Philips North America — Recalls355
Fresenius Medical Care Renal Therapies Group, LLC — Approval records0
Philips North America — Approval records0
Fresenius Medical Care Renal Therapies Group, LLC — Form 483s0
Philips North America — Form 483s0
Timeline
Fresenius Medical Care Renal Therapies Group, LLC
Most recent FDA action: September 9, 2026
Full history →Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Fresenius Medical Care Renal Therapies Group, LLC vs Philips North America: FDA Enforcement Comparison." Argus HQ, accessed September 15, 2026. https://argushq.ai/compare/fresenius-medical-care-renal-therapies-group-llc-vs-philips-north-america
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗